Search results
BMS expands Krazati’s FDA label to include colorectal cancer
Pharmaceutical Technology via Yahoo Finance· 40 minutes agoThe drug’s approved use will be in combination with Eli Lilly’s epidermal growth factor receptor...
EC approves Takeda’s Fruzaqla for metastatic colorectal cancer
Pharmaceutical Technology via Yahoo Finance· 8 hours agoThe European Commission (EC) has approved Takeda’s Fruzaqla (fruquintinib) as a monotherapy for...
FDA Approves Bristol Myers Squibb's Combination Therapy For Colorectal Cancer Patients With Certain...
Benzinga via AOL· 2 hours agoFriday, the FDA granted accelerated approval to Bristol Myers Squibb & Co’s (NYSE:BMY) Krazati...
The 1 Unexpected Sign Of Colon Cancer, According To Doctors
HuffPost Life via Yahoo News· 1 day agoWhile not the most common sign, narrow stools can be indicative of colorectal cancer. Tetra Images...
Aspirin Use Enhances Immunosurveillance in Colorectal Cancer
Medscape· 3 days agoProf David Kerr discusses recent study results related to the impact of aspirin on the tumor...
New immunotherapy shows promise for advanced colorectal cancer in early trial
MedicalNewsToday via AOL· 4 days agoA combination of two monoclonal antibodies was effective in 61% of people with the most common form...
Dame Deborah James ‘saved my life from bowel cancer’
PA Media: Science via Yahoo News· 9 hours agoDr Claire Arthur, consultant oncologist at the Christie, said: “We’re really pleased with Lyndsey’s outcome from the clinical trial. “There’s no evidence...
YOUR HEALTH: Risk factors for early-onset colorectal cancer
WAFB Baton Rouge· 3 days agoThe number of colorectal cancer cases is declining for people 50 and older but going up for younger...
Mainz Biomed CEO discusses stool test for colorectal cancer vs Galleri blood test
BioPharma-Reporter· 4 days agoIn an interview with Biopharma Reporter, Mainz Biomed CEO Guido Baechler explains how his company’s...
US FDA approves Bristol Myers' colorectal cancer therapy
AOL· 3 days ago(Reuters) -The U.S. Food and Drug Administration has approved Bristol Myers Squibb's combination therapy for treating colorectal cancer in patients with ...